CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY) Receives $117.00 Consensus Target Price from Analysts

CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY) has been assigned an average recommendation of “Hold” from the six ratings firms that are currently covering the stock, MarketBeat.com reports. Five analysts have rated the stock with a hold recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $117.00.

CHEOY has been the subject of a number of research reports. Jefferies Financial Group cut shares of CochLear from a “strong-buy” rating to a “hold” rating in a report on Wednesday. Zacks Research raised CochLear from a “strong sell” rating to a “hold” rating in a research note on Monday, June 22nd. UBS Group downgraded CochLear from a “strong-buy” rating to a “hold” rating in a report on Thursday, April 23rd. Finally, Royal Bank Of Canada lowered CochLear from an “outperform” rating to a “sector perform” rating and set a $117.00 price target on the stock. in a research report on Thursday, July 16th.

CochLear Price Performance

Shares of OTCMKTS CHEOY opened at $39.04 on Wednesday. CochLear has a twelve month low of $31.82 and a twelve month high of $105.60. The stock has a fifty day simple moving average of $38.70 and a 200-day simple moving average of $56.91.

CochLear Company Profile

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.